Current population · 2,231
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rah...
← ExplorerSource ↗Publication identity
Publication IDCPD-1221
Year2017
PMID28121498
DOI10.1056/NEJMoa1602615
JournalNot recorded
AuthorsWilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rah...
First authorWilcox MH
Senior authorDorr MB; MODIFY I and MODIFY II Investigators.N Engl J Med.
Scientific classification
Research themePublic health / epidemiology; Clinical infectious diseases
Pathogen groupClostridioides difficile
Technology / methodClinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceIredell J
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/28121498/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →